BlackRock Health Sciences Term Trust Plans Monthly Dividend of $0.09 (NYSE:BMEZ)

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Wednesday, May 1st, Zacks reports. Shareholders of record on Wednesday, May 15th will be given a dividend of 0.09 per share on Friday, May 31st. This represents a $1.08 annualized dividend and a yield of 7.15%. The ex-dividend date is Tuesday, May 14th.

BlackRock Health Sciences Term Trust has raised its dividend payment by an average of 16.5% annually over the last three years.

BlackRock Health Sciences Term Trust Trading Up 1.8 %

Shares of BlackRock Health Sciences Term Trust stock traded up 0.26 during trading hours on Friday, reaching 15.10. The company’s stock had a trading volume of 160,200 shares, compared to its average volume of 322,110. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59. The company’s 50 day simple moving average is 15.74 and its 200 day simple moving average is 14.95.

Insider Buying and Selling

In related news, major shareholder Saba Capital Management, L.P. purchased 193,297 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average price of 15.92 per share, with a total value of 3,077,288.24. Following the acquisition, the insider now owns 19,578,308 shares in the company, valued at approximately 311,686,663.36. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders have acquired a total of 1,142,444 shares of company stock worth $18,333,831 over the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.